Life Science REIT (LON:LABS) Posts Quarterly Earnings Results

Life Science REIT (LON:LABS - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX (8.50) earnings per share for the quarter, Digital Look Earnings reports. Life Science REIT had a negative net margin of 198.99% and a negative return on equity of 14.53%.Get Life Science REIT alerts:Life Science REIT Trading Up 0.3%Shares of LABS stock opened at GBX 39 on Tuesday. The stock has a market cap of £136.50 million, a price-to-earnings ratio of -975.00 and a beta of 0.08. The stock has a 50-day moving average of GBX 39.53 and a 200-day moving average of GBX 41.98. Life Science REIT has a 1-year low of GBX 32 and a 1-year high of GBX 49. About Life Science REIT (Get Free Report)Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.Featured ArticlesFive stocks we like better than Life Science REITWhy Are These Companies Considered Blue Chips?Vertical Aerospace Presents its Blueprint for Sector LeadershipUsing the MarketBeat Stock Split CalculatorHow The Weak Dollar Is Fueling These Global Stock SurgesMost Volatile Stocks, What Investors Need to Know3 Recession-Ready Stocks That Thrive When the Economy SputtersThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Life Science REIT Right Now?Before you consider Life Science REIT, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.While Life Science REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here